About Institut Jules Bordet - Medical Oncology
Het Jules Bordet Instituut is een Brussels, bicommunautair, openbaar ziekenhuis, deel uitmakend van de Iris-groep, dat is gespecialiseerd in oncologie.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
EMD Serono Research & Development Institute, Inc.
1
Puma Biotechnology, Inc.
1
Clinical Trials at Institut Jules Bordet - Medical Oncology
During the past decade, Institut Jules Bordet - Medical Oncology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting
2013-03-29
2019-12-09
Completed
621
Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION)
2022-10-06
2030-12-16
Recruiting
700
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Jules Bordet - Medical Oncology"
#1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Institut Jules Bordet - Medical Oncology
According to Clinical.Site data, the most researched conditions in "Institut Jules Bordet - Medical Oncology" are
"HER2+ Metastatic Breast Cancer (MBC)" (1 trials) and "Head and Neck Cancer" (1 trials). Many other conditions were trialed in "Institut Jules Bordet - Medical Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Institut Jules Bordet - Medical Oncology
Most popular intervention types in "Institut Jules Bordet - Medical Oncology" are "Drug" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "IMRT" (1 trials), "Placebo" (1 trials), "Xevinapant (Debio 1143)" (1 trials), "capecitabine" (1 trials) and "lapatinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Institut Jules Bordet - Medical Oncology
The vast majority of trials in "Institut Jules Bordet - Medical Oncology" are
2 trials for "All" genders.
Clinical Trials Status at Institut Jules Bordet - Medical Oncology
Currently, there are NaN active trials in "Institut Jules Bordet - Medical Oncology".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Institut Jules Bordet - Medical Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Institut Jules Bordet - Medical Oncology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".